|Day Low/High||2.46 / 2.57|
|52 Wk Low/High||1.38 / 4.75|
Walk to End Alzheimer's is Largest Fundraiser Dedicated to Alzheimer's Care, Support and Research Programs
Investors considering a purchase of Genesis Healthcare Inc stock, but tentative about paying the going market price of $3.33/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $2.50 strike, which has a bid at the time of this writing of 15 cents.
Important Clinical Collaboration between Genesis HealthCare and UNM Health System
News of Intesa's potential takeover bid extended Generali's three-day gains to 15%.
Paul Bach Named Successor Chief Operating Officer
In recent trading, shares of Genesis Healthcare Inc have crossed above the average analyst 12-month target price of $2.67, changing hands for $2.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
- NueHealth Patients Now Have Access to Advanced Early Cancer Detection Tests -
Enters Into New Four Year $120 Million Term Loan Agreement; Pays Off Prior Term Loan